Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In November 2023, AstraZeneca and Eccogene signed an exclusive license agreement for ECC5004, an investigational oral once-daily GLP-1RA for treating obesity, type 2 diabetes, and other cardiometabolic conditions
The concentration on your vial determines the answer
This is primarily a loading-phase benefit
Do Not use if the bottle seal is broken or missing
Effective treatments can include: Therapy and Counseling: Cognitive Behavioral Therapy (CBT), motivational interviewing , or other therapies that help identify triggers and develop coping strategies
On the other hand, it may be unpleasant for individuals with already low food intake or sensitive digestion
US$ 21.10
US$ 26.90
US$ 20.72
